Highest-materiality recent filing
Zevia CEO Amy Taylor resigns; board member Alexandre Ruberti named successor; Q2 guidance raised
Amy Taylor resigns as President and CEO effective June 15, 2026 to become CEO of Angel City FC; remains director through Aug 7.
Zevia Q1 net sales up 21% to $46.1M, adjusted EBITDA positive at $0.9M
Net sales $46.1M (+21.2% YoY); driven by 20.4% volume growth, led by Club, Mass, and E-commerce.
Zevia Q4 loss narrows to $1.3M; guides FY2026 rev $169M-$173M, near breakeven EBITDA
Q4 net sales $37.9M (-4% YoY); net loss $1.3M vs $6.8M loss YoY; Adj EBITDA ~$50K vs -$3.9M loss.
Zevia Q3 net sales up 12.3% to $40.8M; Adj. EBITDA loss $1.7M; guides FY2025 sales $162-164M
Net sales grew 12.3% to $40.8M driven by 12.6% volume growth from expanded Walmart & Club distribution.
Zevia Q2 net sales $44.5M (+10.1% YoY); posts positive adj. EBITDA of $0.2M
Net sales grew 10.1% to $44.5M on volume growth of 14.3%; gross margin expanded 680 bps to 48.7%.
Zevia Q4 net sales rise 4.4% to $39.5M, record gross margin 49.2%; guides FY25 rev $158-163M
Q4 net sales $39.5M (+4.4% YoY), volume growth 11.6%; gross margin 49.2% (record, +8.5pp YoY).
Zevia expects Q4 net sales ~$39.5M, revises Adj. EBITDA loss to $3.9-4.2M
Q4 net sales ~$39.5M, at high end of prior outlook; full-year ~$155M.
Zevia Q3 net loss improves to $2.8M; expands Walmart distribution to 4,300 stores
Net sales $36.4M, down 15.6% YoY; gross margin up 3.7 pp to 49.1%.
Zevia regains NYSE minimum price compliance; stock closed above $1 on Sep 30
Received NYSE notice on Oct 1, 2024 confirming compliance with Section 802.01C.
Zevia Q2 net sales $40.4M beat guidance; net loss widens to $7.0M
Net sales $40.4M, down 4.3% YoY; volumes fell 5.9%, partially offset by higher price realizations.
Zevia receives NYSE non-compliance notice for share price below $1.00
Average closing price of Class A common stock below $1.00 over 30 consecutive trading days.
Zevia Q1 net sales $38.8M (-10.4%); net loss $7.2M; launches DSD and cost-cutting plan
Net sales $38.8M, down 10.4% YoY; unit volume fell 10.4% to 3.0M cases.
Hany Mikhail, SVP and CAO, resigns effective May 10, 2024, and will depart July 1, 2024; no dispute with company.
Zevia Q4 net sales up 6.9% to $37.8M but net loss widens to $9.2M; guides Q1 sales $38-40M
Q4 net sales $37.8M (+6.9% YoY), unit volume up 3.7% to 2.8M cases.
Zevia Q3 net sales down 2.6% to $43.1M; net loss widens to $11.3M
Net sales $43.1M vs $44.2M YoY; unit volume down 8.2% to 3.3M cases.
Zevia Q2 net sales down 7.2% to $42.2M; net loss narrows to $5.0M
Net sales $42.2M (-7.2% YoY), unit volume down 16.8% to 3.3M cases.
Zevia preliminary Q2 net sales ~$42M vs outlook $48-51M; FY guidance cut
Preliminary Q2 net sales ~$42M, below prior outlook of $48M-$51M due to supply chain disruptions.
Zevia Q1 net sales +13.8% to $43.3M; gross margin 46.4%; net loss narrows to $2.9M
Net loss of $2.9M vs $17.5M loss in Q1 2022; diluted EPS loss $0.04 vs $0.28.
Zevia Q4 net sales $35.4M (+3.5% YoY); guides FY2023 $180-190M
Q4 net sales $35.4M (+3.5% YoY); gross margin 44.3% (up 1 pt YoY and sequentially).
Zevia Q3 Net Sales $44.2M (+13.6% YoY); Net Loss $9.2M; Resets FY2022 Revenue Guidance to $158-160M
Net sales $44.2M, up 13.6% YoY; unit volume +2.3% to 3.6M cases.
Zevia Q2 net sales $45.5M (+33% YoY), net loss $14.8M; reaffirms FY guidance $177-182M
Net sales of $45.5M beat guidance of $41-43M; unit volume up 30% to 3.9M cases.
Zevia CEO Paddy Spence steps down; President Amy Taylor to become CEO effective Aug 1, 2022
Paddy Spence steps down as CEO effective Aug 1, 2022; remains Non-Executive Chair of the Board.
Zevia Q1 net sales +24% to $38M; net loss widens to $17.5M; CFO departs
Net sales $38.0M, up 24% YoY; unit volume +21% to 3.4M equivalized cases.
Zevia appoints Denise Beckles as CFO and Quincy Troupe as COO, effective May 3 and June 13, 2022
CFO Bill Beech steps down May 3, 2022; COO Hank Margolis retires June 13, 2022.
Zevia reports FY2021 net sales $138.2M (+26%), Q4 loss $37.4M; secures $20M credit facility
Q4 net sales $34.2M (+23% YoY); unit volume 3.0M cases (+22%); gross margin 40.3% vs 42.1% last year.
Zevia Q3 net sales $39M (+22% YoY); net loss $49.8M with $45.7M stock comp
Record net sales $39.0M, up 22% vs Q3 2020; unit volume +26% to 3.5M equivalized cases.
Zevia reports record Q2 net sales of $34.4M but net loss widens; CEO takes $1 salary
Net sales $34.4M (+24% YoY), record high; gross margin 47% vs 50% due to higher trade discounts.
Zevia PBC appoints nine new directors and amends charter/bylaws in connection with IPO
Board appointed nine new directors: Jacqueline Hayes, Brian McGuigan, Philip Hunter O'Brien, Rosemary Ripley, Andrew Ruben, Julie Garcia Ruehl, Justin Shaw, Amy Taylor, Quincy Troupe.
Effective June 15, 2026 (the “Effective Date”), the Board appointed current director Alexandre I. Ruberti to succeed Ms. Taylor as the Company’s President and Chief Executive Officer.
On June 10, 2026, Amy E. Taylor notified Zevia PBC (the “Company”) of her resignation as President and Chief Executive Officer of the Company, effective June 15, 2026.
On June 12, 2025, Rosemary Ripley, a member of the Board of Directors (the “Board”) of Zevia PBC (the “Company”), notified the Company that she will be stepping down from the Board, effective as of June 12, 2025.
On February 6, 2025, Zevia PBC (the “Company”) and Ms. Lorna R. Simms, the Company’s SVP, General Counsel and Corporate Secretary, mutually agreed to terms pursuant to which Ms. Simms will step down as the Company’s SVP, General Counsel and Corporate Secretary and separate from employment effective as of April 4, 2025.
On September 26, 2024 (the “Effective Date”), the Board of Directors (the “Board”) of Zevia PBC (the “Company”) accepted the resignation of Jacqueline J. Hayes who notified the Company that she will resign from the Board effective September 27, 2024 in order to focus her attention on a new senior executive position at another company.
increased the size of the Board from eight to nine members and appointed Alexandre I. Ruberti as an independent Class III director of the Company, effective as of August 6, 2024
On June 24, 2024, Greig P. DeBow, Jr. informed Zevia PBC (the “Company”) that he intends to resign as Executive Vice President and Chief Commercial Officer of the Company to pursue other opportunities. Mr. DeBow’s resignation will be effective as of the close of business on July 3, 2024.
On April 12, 2024, Hany Mikhail informed Zevia PBC (the “Company”) that he intends to resign as Senior Vice President and Chief Accounting Officer of the Company to pursue other opportunities.
Effective May 11, 2024, Girish Satya, Chief Financial Officer of the Company, will serve as the Company’s principal accounting officer.
On the Effective Date, Florence Neubauer will no longer serve as Interim Chief Financial Officer of the Company.
it had appointed Girish Satya, to serve as the Company’s Chief Financial Officer with an effective date of February 21, 2024
Andrew Ruben has been appointed to serve as Lead Independent Director of the Company.
Max materiality 0.80 · Median 0.60 · Most common event earnings